Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Clinical trial NCT01198158 · TERMINATED
Trial details
- NCT number
- NCT01198158
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-15
- Primary completion
- 2017-12-15
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.